Longitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii515
Main Authors Palma, J., Vitazka, P., Tikoo, N., Balasubramanyam, A., Xi, L., Yaung, S., Kwok, E., Lovejoy, A., Klass, D., Heibeck, M., Probst, K., Rehfeldt, A., Meldgaard, E., Madsen, A., Clement, M., Sorensen, B., Meldgaard, P.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text
ISSN0923-7534
1569-8041
DOI10.1093/annonc/mdy292.048

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy292.048